113 related articles for article (PubMed ID: 22507914)
21. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia.
Jain S; Sharma B
Physiol Behav; 2015 Dec; 152(Pt A):182-93. PubMed ID: 26382939
[TBL] [Abstract][Full Text] [Related]
22. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
23. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.
Borde P; Mohan M; Kasture S
Nat Prod Res; 2011 Sep; 25(16):1549-59. PubMed ID: 21391110
[TBL] [Abstract][Full Text] [Related]
24. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.
Galisteo M; García-Saura MF; Jiménez R; Villar IC; Wangensteen R; Zarzuelo A; Vargas F; Duarte J
Planta Med; 2004 Apr; 70(4):334-41. PubMed ID: 15095149
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
Singh P; Gupta S; Sharma B
Curr Neurovasc Res; 2016; 13(3):219-29. PubMed ID: 27189349
[TBL] [Abstract][Full Text] [Related]
26. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
27. Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.
Sharma P; Gaur N; Jayant S; Sharma BM; Singh B; Kharkwal H; Sharma B
Pharmacol Rep; 2022 Jun; 74(3):481-492. PubMed ID: 35396697
[TBL] [Abstract][Full Text] [Related]
28. Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of streptozotocin diabetes induced dementia.
Bhatia P; Singh N
Physiol Behav; 2021 Nov; 241():113592. PubMed ID: 34534530
[TBL] [Abstract][Full Text] [Related]
29. Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.
Sharma B; Singh N
Curr Neurovasc Res; 2010 Aug; 7(3):180-91. PubMed ID: 20560881
[TBL] [Abstract][Full Text] [Related]
30. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Singh B; Sharma B; Jaggi AS; Singh N
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):124-36. PubMed ID: 23060470
[TBL] [Abstract][Full Text] [Related]
31. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
Bhatia P; Kaur G; Singh N
Vascul Pharmacol; 2021 Apr; 137():106827. PubMed ID: 33346090
[TBL] [Abstract][Full Text] [Related]
32. Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia.
Bhatia P; Singh N
Curr Neurovasc Res; 2019; 16(1):27-39. PubMed ID: 30706814
[TBL] [Abstract][Full Text] [Related]
33. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
35. Beneficial Effect of Protein Tyrosine Phosphatase Inhibitor and Phytoestrogen in Dyslipidemia-Induced Vascular Dementia in Ovariectomized Rats.
Verma A; Sharma S
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2434-46. PubMed ID: 26324516
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological evidence of calcium-channel blockade by essential oil of Ocimum gratissimum and its main constituent, eugenol, in isolated aortic rings from DOCA-salt hypertensive rats.
Interaminense LF; Jucá DM; Magalhães PJ; Leal-Cardoso JH; Duarte GP; Lahlou S
Fundam Clin Pharmacol; 2007 Oct; 21(5):497-506. PubMed ID: 17868202
[TBL] [Abstract][Full Text] [Related]
37. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
Singh P; Gupta S; Sharma B
Physiol Behav; 2015 Apr; 142():66-78. PubMed ID: 25659733
[TBL] [Abstract][Full Text] [Related]
38. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Tyagi S; Sharma S; Budhiraja RD
Can J Physiol Pharmacol; 2012 Jul; 90(7):881-5. PubMed ID: 22731503
[TBL] [Abstract][Full Text] [Related]
39. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y
Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524
[TBL] [Abstract][Full Text] [Related]
40. A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats.
Bankar GR; Nampurath GK; Nayak PG; Bhattacharya S
Chem Biol Interact; 2010 Jan; 183(2):327-31. PubMed ID: 19912999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
